Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Soy Protein and Reduced Soluble Fas to Fas Ligand Ratio

Doses used in studies

g/day: 19.2 (median 19.2, IQR 19.2–19.2) — 1 study

Time to effect

Median: 24.3 months · IQR 24.3 months–24.3 months · Range 24.3 months–24.3 months — Reported in 1 of 1 study

1 of 1 paper

Impact of 18-Month Soy Protein Supplementation on Steroid Hormones and Serum Biomarkers of Angiogenesis, Apoptosis, and the Growth Hormone/IGF-1 Axis: Results of a Randomized, Placebo-Controlled Trial in Males Following Prostatectomy.
- 2021-01-12
- RCT
- Nutrition and cancer 74(1)
- - Maarten C Bosland
  - Jonathan Huang
  - Michael J Schlicht
  - Erika Enk
  - Hui Xie
  - Ikuko Kato
- PubMed: 33432829
- DOI: 10.1080/01635581.2020.1870706
17 Insights on
- Reduced Soluble Fas to Fas Ligand Ratio
- High evidence
- Clinical
did not affect serum concentrations of ... sFas/Fas-ligand ratio
Effect
Neutral
Effect size
Small
Significant
No
Dose
19.2 g/day of whole soy protein isolate containing 24 mg genistein